… of skin and mucosal disease, without side effects [36-43]. IVIg has been reported to be
effective in patients with linear IgA bullous disease [44-46] and pemphigoid gestationis [47]. The …

… the management of autoimmune blistering diseases (AIBD) … serious acute and long-term
side effects. The advent of … measures are effective in minimizing the adverse outcomes …

… Pemphigus is a group of rare autoimmune blistering diseases… has been reported and reducing
or stopping the medication if … systemic complications, as well as the potential autoimmune …

… by reducing autoantibodies … blistering and restore the skin barrier with fewer side effects. In
this review, we highlight the different mechanisms behind autoimmune skin blistering disease …

… Presently, the common causes of death are complications of therapeutic agents. … Other
studies have shown it effective at reducing serum levels of autoantibodies and controlling …

… as well, such as linear IgA bullous disease and pemphigoid (herpes) gestationis, among
others… Sometimes doses can be lowered or given on alternate days to minimize adverse effects. …

… with different autoimmune bullous diseases, … reducing cumulative exposure to systemic
corticosteroids. Moreover, in eight of our cases, MPA was added because of serious side effects …

… Rituximab use is increasingly common for autoimmune blistering skin diseases. Placental
… recovery without infectious complications. The lack of serious infectious complications in the …

… It is often preferable to use lower dosages and give the corticosteroids on alternate days to
minimize side effects. Other anti-inflammatory drugs have been used to treat pemphigus and …

… Since autoimmune bullous diseases may result in significant … the corticosteroid load and
minimize side effects such as … approaches to autoimmune bullous diseases, also including …